Pharma Articles - Insights & Trends | World Pharma Today

Why More Data Doesn’t Automatically Mean Better AI in Drug Discovery

Yuvraj — Mon, 17 Aug 2026 07:18:26 +0000

When DeciBio asked nine senior pharma executives what was holding back AI adoption in R&D, the answer wasn’t algorithms or compute. Three of the top four barriers they named were data problems, and low-quality data was cited by every single one of them. Every AI drug discovery pitch deck has a slide about proprietary data. […]

The post Why More Data Doesn’t Automatically Mean Better AI in Drug Discovery first appeared on World Pharma Today.

Beyond the Purity Percentage

Yuvraj — Thu, 06 Aug 2026 08:06:15 +0000

How pharmaceutical and life-science R&D teams can qualify high-purity specialty inorganic salts using rubidium chloride and rubidium carbonate to illustrate the importance of impurity profiles, analytical evidence, packaging and supplier consistency. Rubidium Carbonate Rubidium Chloride Qualification at a glance Focus: Impurity profile, evidence, consistency and control Use cases: Pharma, life science, diagnostics and formulation R&D […]

The post Beyond the Purity Percentage first appeared on World Pharma Today.

The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients

Yuvraj — Fri, 12 Jun 2026 09:57:32 +0000

How advanced analytical methods, potency assays, and immune profiling are shaping the future of cancer cell therapies Cell therapies have transformed the treatment landscape for patients with cancer and other serious diseases. Innovations such as CAR-T cell therapies have demonstrated remarkable clinical success, offering new treatment options for patients with limited alternatives. While much of […]

The post The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients first appeared on World Pharma Today.

Stevanato Group and Syntegon Join Forces to Drive Innovation

Yuvraj — Tue, 02 Jun 2026 13:27:06 +0000

Quality first: advanced manufacturing process for EZ-fill® cartridges The development of GLP-1 drugs has revolutionized the treatment of diabetes and obesity – and is a catalyst for breaking new grounds in ready-to-use cartridge manufacturing. Primary packaging provider Stevanato Group has teamed up with equipment supplier Syntegon to develop an advanced manufacturing process for Stevanato Group’s […]

The post Stevanato Group and Syntegon Join Forces to Drive Innovation first appeared on World Pharma Today.

Move Beyond Visibility: Why Cold Chain Orchestration is Now Essential for Thermal Assurance

Yuvraj — Thu, 07 May 2026 12:00:58 +0000

As life sciences supply chains become more volatile, real-time visibility is increasingly the baseline for operational excellence. The next frontier is orchestration: turning fragmented signals into decisions that prevent excursions, reduce waste, and protect patients. Sam Durham, Product Manager – Digital Solutions & Services at Cold Chain Technologies, explains the role of digital technology in […]

The post Move Beyond Visibility: Why Cold Chain Orchestration is Now Essential for Thermal Assurance first appeared on World Pharma Today.

Speed in complex drug development is the late-phase outcome of early-phase decisions

Yuvraj — Fri, 17 Apr 2026 13:50:20 +0000

Late-stage development is where timelines tighten, complexity increases, and the demand for speed becomes most visible. Execution is often treated as the lever—compressed timelines, parallel workstreams, faster decision-making. But speed is rarely created at that stage. It is shaped earlier, through decisions made when flexibility is still high and the cost of change is lower. […]

The post Speed in complex drug development is the late-phase outcome of early-phase decisions first appeared on World Pharma Today.

The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement

Yuvraj — Mon, 06 Apr 2026 08:17:20 +0000

Why Field Execution Must Evolve Field execution — how pharma companies organize, direct, and deliver commercial and medical interactions with healthcare professionals (HCPs), prescribers, and institutional decision-makers (collectively, “customers”) — is a major contributor to commercial success. Accordingly, over the past decade, companies have invested heavily in sales force effectiveness, key account management, omnichannel strategies, […]

The post The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement first appeared on World Pharma Today.

4 Critical Peel Testing Parameters for Pharmaceutical Blister Packaging

Yuvraj — Fri, 03 Apr 2026 09:38:31 +0000

A blister pack may seem like a simple enough concept until you’re trying to prove that it will open cleanly every time. Peel testing turns each peel into data so you can protect dose integrity, support and child resistance and avoid line surprises. What Peel Testing Measures Peel testing measures the force required to separate […]

The post 4 Critical Peel Testing Parameters for Pharmaceutical Blister Packaging first appeared on World Pharma Today.

Integrating high-voltage leak detection into automated visual inspection

Yuvraj — Fri, 20 Mar 2026 11:21:51 +0000

The protection of patient health starts with ensuring the safety of pharmaceutical products even before they reach healthcare providers. Every recall caused by defective or leaking containers is one too many. As the pharmaceutical industry continues to evolve towards safer processes, a key trend is driving positive change: the growing demand for leak detection complementary […]

The post Integrating high-voltage leak detection into automated visual inspection first appeared on World Pharma Today.

Aligning Global Clinical Trials with Standardized Drug Data

Yuvraj — Mon, 23 Feb 2026 06:18:42 +0000

Modern drug development necessitates a shift from fragmented data silos to a unified, intelligence-driven framework. Achieving global regulatory alignment requires a sophisticated approach to trial documentation standards and pharmaceutical regulatory governance, ensuring that clinical trial design remains robust across multiple jurisdictions. By leveraging standardized drug intelligence, sponsors can enhance submission readiness and maintain cross-border compliance, ultimately accelerating the delivery of life-saving therapies to patients worldwide.

The post Aligning Global Clinical Trials with Standardized Drug Data first appeared on World Pharma Today.